Stock VRAX VIRAX BIOLABS GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Virax Biolabs Group Limited

Equities

VRAX

KYG9495L1251

Market Closed - Nasdaq
Other stock markets
 21:30:01 17/05/2024 BST 		5-day change 1st Jan Change
0.8395 USD +7.13% Intraday chart for Virax Biolabs Group Limited +4.94% -42.50%
04-25 Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024 CI
01-12 Virax Biolabs Group Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VIRAX BIOLABS GROUP LIMITED Stock Virax Biolabs Group Limited
 1.98M - - - - -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 42.12B
LONZA GROUP AG Stock Lonza Group AG
 42.05B
CELLTRION, INC. Stock Celltrion, Inc.
 29.18B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.02B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 18.9B -
  1. Stock Market
  2. Equities
  3. VRAX Stock
  4. Charts Virax Biolabs Group Limited
  5. Sector Chart